The article presents the views of financial analyst and investment banker regarding the future conditions of biotechnology industry. The financial analyst predicted that there will be a change in investors focus towards earnings and financial metrics. They predicted that the successful biotech companies will be those that changes in tune with innovations while driving the organization towards growth.